RECORDS ARE PUBLISHED REGULATORY ACTIONS. FIELDS THE ISSUING AUTHORITY DID NOT PUBLISH ARE MARKED AS NOT STATED, NEVER FILLED IN.
Drug Eye AfricaNational Actions, Continental Reach
اقرأ هذه الصفحة بـ: English · العربية · Français · Português
Register / Egypt / DEA-EG-2026-8263
Egyptian Drug Authority · Egypt
DEA-EG-2026-8263
Tier 1 · Regulator-publishedUnclassifiedتحذير للجمهورStatus · active
Issuing authority
Egyptian Drug Authority (EDA)
Authority reference
report no.(8263) For 2026
Date issued
Sept 2026
Recorded by us
2026-09-10 17:14:57 UTC
المستحضر
PERFORMA EXTRA STRENGTH 5 % MINOXIDIL 5% For Men & Women
INN / active substance
Not stated by the issuing authority
Dosage form
Not stated by the issuing authority
Strength
Not stated by the issuing authority
الشركة المصنعة
Not stated by the issuing authority
Manufacturer country
Not stated by the issuing authority
MAH or importer
Not stated by the issuing authority
أرقام التشغيلات
Not published with the notice
تواريخ انتهاء الصلاحية
Not published with the notice
Action type
تحذير للجمهور
التصنيف
Not stated by the issuing authority
Indicative severity
Not assessed by Drug Eye Africa
Defect category
Not stated by the issuing authority
Product type
Not stated by the issuing authority
ATC code
Not stated by the issuing authority
Affected markets
Egypt — no market beyond the issuing country was named on the notice
Cross-border event
Not linked to a cross-border event
نص الإخطار
PERFORMA EXTRA STRENGTH 5 % MINOXIDIL 5% For Men & Women 251034 11/2028-11/2025 Al Andalous for pharmaceutical industries تداول عبوات مجهولة المصدر من الصنف الموضح وذلك بناءً على ما ورد الينا من شركة Al Andalous for pharmaceutical industries صاحبة المستحضر بأن العبوات بالاختلافات الموضحة لا تخصها ولم يتم انتاجها او تصنيعها بمعرفتهم ويمكن تمييزالعبوات مجهولة المصدر كما هو موضح بالرابط ضبط وتحريز العبوات الغير مطابقة للمواصفات من المستحضر المغشوش طبقا لما هو وارد بالرابط في حالة الشك في المستحضر الصيدلى يتم الرجوع الى هيئة الدواء المصرية سواء بالإتصال بالخط الساخن 15301او الموقع الإلكترونى الخاص بالهيئة. يمكن الضغط على الرابطللإطلاع على الصور الخاصة بالمستحضر المقلد. سبتمبر2026 منشور غش تجاري اسم المستحضر سبب التحذير الإجراءات التصحيحية نصائح للمستهلكين هذا التنبيه خاص بالتشغيلات الواردة في المنشور فقط ولا ينطبق على تداول المستحضر بشكل عام رقم التشغيلة تاريخ الانتاج و الانتهاء الشركة صاحبة المستحضر
الحالة
سارٍ
Superseded by
Not superseded. This is the current version.
Version
7

Provenance

Verification tier 1

Where this record came from, and what is held to show it.

Copy of the source
Taken and held by Drug Eye Africa, so the record survives the link above being moved or withdrawn. Not yet published at an address you can open.
Ask us for it and check it against the fingerprint below.
Fingerprint
93b468bdce4b4cebdae01e8e81bcbae8e41eb2f5929f3793a22d18026248644d
SHA-256 of the copy held. Any file that produces this number is that copy, byte for byte; any file that does not is a different document.
Copy taken
2026-09-10 17:18:18 UTC
Cite this record
Drug Eye Africa (2026). DEA-EG-2026-8263: PERFORMA EXTRA STRENGTH 5 % MINOXIDIL 5% For Men & Women — تحذير للجمهور, Egyptian Drug Authority. Register of African Regulatory Actions. https://drugeyeafrica.org/register/notice/eg/2026/dea-eg-2026-8263

Version history

No version history recorded for this record.
Corrections appear here and in the site-wide log. Records are superseded, never deleted.

Verification

Tier 1Published by the issuing regulator on its own channel and captured by Drug Eye Africa, with the source document archived.

Indexing

This record is indexable: it is dated, names a product, and carries either a batch number or a stated reason.